Frankfurt - Delayed Quote EUR
Heron Therapeutics, Inc. (AXD2.F)
1.9040
-0.0670
(-3.40%)
At close: May 9 at 8:05:50 AM GMT+2
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 1.03M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| FORBES WILLIAM P Officer | -- | Direct | -- | Apr 30, 2025 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Apr 30, 2025 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Apr 30, 2025 |
| FORBES WILLIAM P Officer | -- | Direct | -- | Apr 17, 2025 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Apr 17, 2025 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Apr 17, 2025 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Apr 3, 2025 |
| JOHNSON CRAIG A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| KASETA MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| RODRIGUEZ SUSAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| DISSANAIKE SHARMILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| MORGAN ADAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| CHRISTIAN WAAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 31, 2025 |
| JOHNSON CRAIG A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| KASETA MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| RODRIGUEZ SUSAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| DISSANAIKE SHARMILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| MORGAN ADAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| CHRISTIAN WAAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 30, 2025 |
| FORBES WILLIAM P Officer | -- | Direct | -- | Jan 17, 2025 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Jan 17, 2025 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Jan 17, 2025 |
| KASETA MICHAEL Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
| FORBES WILLIAM P Officer | -- | Direct | -- | Oct 18, 2024 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Oct 18, 2024 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Oct 18, 2024 |
| FORBES WILLIAM P Officer | -- | Direct | -- | Jul 19, 2024 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Jul 19, 2024 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Jul 19, 2024 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Jun 14, 2024 |
| FORBES WILLIAM P Officer | -- | Direct | -- | Jun 6, 2024 |
| FORBES WILLIAM P Officer | -- | Direct | -- | Apr 19, 2024 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Apr 19, 2024 |
| DUARTE IRA Chief Financial Officer | -- | Direct | -- | Apr 19, 2024 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | -- | Direct | -- | Apr 3, 2024 |
| JOHNSON CRAIG A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| RODRIGUEZ SUSAN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| DISSANAIKE SHARMILA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| MORGAN ADAM Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| CHRISTIAN WAAGE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 19, 2024 |
| PERAZA LISA Officer | -- | Direct | -- | Jan 12, 2024 |
| FORBES WILLIAM P Officer | Purchase at price 1.09 per share. | Direct | 27,250 | Nov 17, 2023 |
| FORBES WILLIAM P Officer | Purchase at price 0.94 per share. | Direct | 46,995 | Nov 16, 2023 |
| COLLARD CRAIG ALEXANDER Chief Executive Officer | Purchase at price 0.92 per share. | Direct | 137,970 | Nov 16, 2023 |
| DUARTE IRA Chief Financial Officer | Purchase at price 0.89 per share. | Direct | 75,599 | Nov 16, 2023 |
| PERAZA LISA Officer | -- | Direct | -- | Oct 13, 2023 |
| MORGAN ADAM Director | Purchase at price 1.37 per share. | Indirect | 3,406,839 | Jul 21, 2023 |
| SZEKERES DAVID LESLIE Chief Operating Officer | -- | Direct | -- | Jul 13, 2023 |
| PERAZA LISA Officer | -- | Direct | -- | Jul 13, 2023 |
Related Tickers
IKAP.DU Aurinia Pharmaceuticals Inc
7.03
-2.60%
1244.HK 3D MEDICINES
3.020
-3.51%
RNAC Cartesian Therapeutics, Inc.
9.90
-4.99%
PYXS Pyxis Oncology, Inc.
1.0700
-1.83%
SGMT Sagimet Biosciences Inc.
3.2600
+1.87%
AUPH Aurinia Pharmaceuticals Inc.
8.00
-1.36%
GPCR Structure Therapeutics Inc.
25.57
-4.66%
PSTV Plus Therapeutics, Inc.
0.6600
+6.45%
PLX Protalix BioTherapeutics, Inc.
1.7200
-40.48%
VERV Verve Therapeutics, Inc.
4.2300
-5.58%